FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Vancomycin Hydrochloride | Vancomycin hydrochloride 750 mg/1 | Injection, Powder, For solutionIntravenous, Oral | Avenacy, LLC | Aug 15, 2026 | 83634-114 |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 1.25 g/1 | Injection, Powder, For solutionIntravenous, Oral | Avenacy, LLC | Aug 15, 2026 | 83634-115 |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 1.5 g/1 | Injection, Powder, For solutionIntravenous, Oral | Avenacy, LLC | Aug 15, 2026 | 83634-116 |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | Injection, SolutionIntravenous | Avenacy, LLC | Aug 15, 2026 | 83634-655 |
| Lucemyralofexidine hydrochloride | Lofexidine hydrochloride .2 mg/1 | Tablet, Film coatedOral | BioCorRx Pharmaceuticals Inc | Aug 15, 2026 | 85789-801 |
| Lofexidinelofexidine hydrochloride | Lofexidine hydrochloride .2 mg/1 | Tablet, Film coatedOral | BioCorRx Pharmaceuticals Inc | Aug 15, 2026 | 85789-901 |
| sodium bicarbonate | Sodium bicarbonate 12.6 mg/mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | Aug 14, 2026 | 0338-0822 |
| Trazodone Hydrochloride | Trazodone hydrochloride 50 mg/1 | TabletOral | American Health Packaging | Aug 14, 2026 | 60687-954 |
| ondansetron hydrochloride | Ondansetron hydrochloride 4 mg/1 | Tablet, Film coatedOral | Ipca Laboratories Limited | Aug 14, 2026 | 83980-017 |
| ondansetron hydrochloride | Ondansetron hydrochloride 8 mg/1 | Tablet, Film coatedOral | Ipca Laboratories Limited | Aug 14, 2026 | 83980-018 |
| Zenbexusiberdomide | Iberdomide hydrochloride .75 mg/1 | CapsuleOral | E.R. Squibb & Sons, L.L.C. | Aug 13, 2026 | 0003-5700 |
| Zenbexusiberdomide | Iberdomide hydrochloride 1 mg/1 | CapsuleOral | E.R. Squibb & Sons, L.L.C. | Aug 13, 2026 | 0003-5710 |
| Erythromycin Lactobionate | Erythromycin lactobionate 500 mg/1 | Injection, Powder, For solutionIntravenous | Piramal Critical Care Inc. | Aug 13, 2026 | 66794-251 |
| Prednisone delayed releaseprednisone | Prednisone 5 mg/1 | Tablet, Delayed releaseOral | Dr. Reddys Laboratories Inc. | Aug 12, 2026 | 43598-888 |
| Valacyclovir | Valacyclovir hydrochloride 1000 mg/1 | TabletOral | St. Mary's Medical Park Pharmacy | Aug 12, 2026 | 60760-856 |
| Lansoprazole | Lansoprazole 30 mg/1 | Capsule, Delayed release pelletsOral | Preferred Pharmaceuticals Inc. | Aug 12, 2026 | 68788-4141 |
| acyclovir | Acyclovir 50 mg/g | OintmentTopical | c | Aug 12, 2026 | 68788-4142 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | Aug 12, 2026 | 68788-4143 |
| Famotidine | Famotidine 40 mg/1 | Tablet, Film coatedOral | Preferred Pharmaceuticals Inc. | Aug 12, 2026 | 68788-4144 |
| Tamsulosin Hydrochloride | Tamsulosin hydrochloride .4 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | Aug 12, 2026 | 68788-4145 |
| Dicyclomine hydrochloride | Dicyclomine hydrochloride 20 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | Aug 12, 2026 | 68788-4146 |
| Haloperidol | Haloperidol 10 mg/1 | TabletOral | REMEDYREPACK INC. | Aug 12, 2026 | 70518-4725 |
| Celecoxib | Celecoxib 200 mg/1 | CapsuleOral | REMEDYREPACK INC. | Aug 12, 2026 | 70518-4726 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Direct_Rx | Aug 12, 2026 | 72189-683 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | Direct_Rx | Aug 12, 2026 | 72189-684 |